PDX Pharmaceuticals is Pharmaceuticals in United States that focus on nanoparticle core business. Founded in 2010. They cover business area such as developer, functionalize nanomaterial, health care, nanotechnology, a hybrid, polymer coating, inorganic nanoparticle core, novel nanomaterial, researcher, patient, cure, breast, prostate, cancer, fibrosis, hyperphosphatemia.
2010
( 14 years old in 2024 )
Nanoparticle Core
-
3303 South West Bond Avenue
13th Floor, Center for Health & Healing Building 1
Portland, OR 97239
United States
Private
developerfunctionalize nanomaterialhealth carenanotechnologya hybridpolymer coatinginorganic nanoparticle corenovel nanomaterialresearcherpatientcurebreastprostatecancerfibrosishyperphosphatemia
* We use standard office opening hours in near PDX Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
PDX Pharmaceuticals is Pharmaceuticals business from United States that founded in 2010 (14 years old in 2024), PDX Pharmaceuticals business is focusing on Nanoparticle Core.
PDX Pharmaceuticals headquarter office and corporate office address is located in 3303 South West Bond Avenue 13th Floor, Center for Health & Healing Building 1 Portland, OR 97239 United States.
PDX Pharmaceuticals was founded in United States.
In 2024, PDX Pharmaceuticals is currently focus on nanoparticle core sector.
Above is snippet of Google Trends for "nanoparticle core" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with PDX Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
